UBS Group’s Loncar China BioPharma ETF CHNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
|
|||||
|
2022
Q4 | $4.73K | Sell |
|
|||||
|
2022
Q3 | $16K | Sell |
|
|||||
|
2022
Q2 | $32K | Buy |
|
|||||
|
2022
Q1 | $17K | Sell |
|
|||||
|
2021
Q4 | $29K | Buy |
|
|||||
|
2021
Q3 | $36K | Buy |
|
|||||
|
2021
Q2 | – | Sell |
|
|||||
|
2021
Q1 | $62K | Buy |
|
|||||
|
2020
Q4 | $13K | Sell |
|
|||||
|
2020
Q3 | $27K | Buy |
|
|||||
|
2020
Q2 | $11K | Sell |
|
|||||
|
2020
Q1 | $26K | Buy |
|
|||||
|
2019
Q4 | $18K | Buy |
|
|||||
|
2018
Q4 | – | Sell |
|
|||||
|
2018
Q3 | $10K | Buy |
|